Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Translational Gastroenterology and Hepatology|February 1, 2017
Multiple localized metachronous recurrences in a patient of colon cancer and therapeutic controversies in stage II colon cancerVijai Simha, Rakesh Kapoor, Saniya Sharma
Journal of Gastrointestinal Oncology|August 2, 2014
Mucinous adenocarcinoma of the rectum: a poor candidate for neo-adjuvant chemoradiation?Vijai Simha, Rakesh Kapoor, Rajesh Gupta, et al.
Journal of Contemporary Brachytherapy|June 3, 2015
Evaluation of neuropathic pain occurring after high-dose-rate interstitial brachytherapy of oral tongueVijai Simha, Suresh C Sharma, Rakesh Kapoor, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 30, 2014
Vaginal dose, toxicity and sexual outcomes in patients of cervical cancer undergoing image based brachytherapyBhavana Rai, Bhaswanth Dhanireddy, Firuza Darius Patel, et al.
Brachytherapy|July 18, 2014
Evaluation of intrafraction motion of the organs at risk in image-based brachytherapy of cervical cancerVijai Simha, Firuza Darius Patel, Suresh Chander Sharma, et al.
South Asian Journal of Cancer|July 16, 2021
Presentation and Outcomes with First-Line Chemotherapy in Advanced Cholangiocarcinomas-A Relatively Rare Component of Biliary Tract Cancers in IndiaPrabhat G Bhargava, Amit Kumar, Vijai Simha, et al.
South Asian Journal of Cancer|November 16, 2018
Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancersAnant Ramaswamy, Vikas Ostwal, Kushal Gupta, et al.
South Asian Journal of Cancer|September 7, 2019
Palliative chemotherapy in carcinoma nasopharynxVijay M Patil, Amit Joshi, Vanita Noronha, et al.
Brachytherapy|November 6, 2017
Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experienceVijai Simha, Bhavana Rai, Firuza D Patel, et al.
Journal of Global Oncology|September 23, 2018
Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non-High-Dose Methotrexate-Based, Dose-Dense Combination Chemotherapy, in a Tertiary Care Cancer CenterJyoti Bajpai, Arun Chandrasekharan, Vijai Simha, et al.
Pageof 2